syriQ BioPure® Ready-to-use prefillable glass syringes for storing and administering highly sensitive biologics
Request quotesyriQ BioPure®: Prefillable glass syringes for biologics
Biologic drugs are highly sensitive and prone to interaction with primary packaging materials. Residuals such as glass ions, silicone oil, and tungsten can compromise drug stability, leading to protein aggregation or degradation. These risks are especially critical for high-concentration and high-viscosity formulations.syriQ BioPure® prefillable glass syringes for biologics are engineered to address these challenges. Manufactured from high-quality FIOLAX® Type I Borosilicate Glass, SCHOTT Pharma’s syriQ BioPure® glass syringes deliver outstanding functionality, safe and easy drug administration, and a high level of patient comfort. They feature low particle levels as well as ultra-low tungsten and glue residuals.
With tight dimensional tolerances and optimized siliconization, syriQ BioPure® prefillable glass syringes ensure consistent gliding forces and reliable performance, and are verified for seamless integration with large-volume autoinjectors and safety systems.
With pre-validated configurations and comprehensive documentation, the platform approach of SCHOTT Pharma’s prefillable syringes for biologics results in a fast time-to-market, making syriQ BioPure® the ideal solution for biologic therapies.
Enhanced drug stability and seamless device integration
Manufactured using advanced technology and high-quality FIOLAX® Type I Borosilicate Glass, SCHOTT Pharma’s syriQ BioPure® glass syringes offer ultra-low levels of tungsten and glue residuals, as well as a reduced subvisible particle load to provide long-term drug stability across the entire shelf life.
Safe and reliable administration of highly sensitive biologics at home
syriQ BioPure® prefillable glass syringes for biologics from SCHOTT Pharma are specifically designed for the safe storage and precise administration of highly sensitive drugs. Their low, uniform silicone levels and tight dimensional specifications support consistent gliding forces and injection times, ensuring compatibility with safety devices and the leading autoinjector platforms, making them ideal for homecare applications.SCHOTT Pharma’s syriQ BioPure® ready-to-use glass syringes come pre-washed and pre-sterilized in a nest and tub configuration.
|
|
|
|
|
| Product Name |
Product Name
syriQ BioPure®
|
Product Name
syriQ®
|
Product Name
syriQ BioPure® silicone-free
|
| Applications |
Applications
Biologics, Large-volume drugs
|
Applications
Variety of vaccines, including inactivated (flu shot), live-attenuated (MMR), subunit and recombinant vaccines (HPV) and breakthrough mRNA vaccines, diluent applications
|
Applications
Silicone-sensitive biologics
|
| Tubing Container Material |
Tubing Container Material
FIOLAX® Type I (CHR**) Borosilicate Glass
|
Tubing Container Material
FIOLAX® Type I Borosilicate Glass
|
Tubing Container Material
FIOLAX® Type I CHR** Borosilicate Glass
|
| Format |
Format
1 ml lg staked needle, 2.25 ml staked needle, 5.5 ml staked needle
|
Format
0.5 - 3 ml
|
Format
1 ml staked needle, 2.25 ml staked needle upon request
|
| Closure Systems |
Closure Systems
Rigid Needle Shield (RNS)
|
Closure Systems
syriQ® Rigid Cap (SRC) or OVS®*
|
Closure Systems
Rigid Needle Shield (RNS)
|
| Pre-washed, Pre-sterilized |
Pre-washed, Pre-sterilized
RTU
|
Pre-washed, Pre-sterilized
RTU
|
Pre-washed, Pre-sterilized
RTU
|
| Packaging |
Packaging
Pre-sterilized syringes in tub- and nest-configuration
|
Packaging
Pre-sterilized syringes in tub- and nest-configuration
|
Packaging
Pre-sterilized syringes in tub- and nest-configuration
|
| Read More | Read More |
* OVS® is a registered trademark of Vetter-Pharma International GmbH, Germany
** Controlled hydrolytic resistance (CHR)